These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35991059)

  • 1. The Relationship Between Enterprise Financial Risk and R&D Investment Under the Influence of the COVID-19.
    Li X; Cheng B; Li Y; Duan J; Tian Y
    Front Public Health; 2022; 10():910758. PubMed ID: 35991059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model.
    Yang J; Wang L; Sun Z; Zhu F; Guo Y; Shen Y
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tax Incentives, Tax Enforcement, and Enterprise R&D Investment: Evidence From Chinese A-Share Listed.
    Sun Y
    Front Psychol; 2022; 13():953313. PubMed ID: 35874375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of enterprise financialization on green innovation: evidence from Chinese A-share non-financial listed enterprises.
    Li W; Chen L; He S
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):56802-56817. PubMed ID: 36929262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tax preference, financing constraints and enterprise investment efficiency-Experience, of China's enterprises investment.
    Zhai L; Feng Y; Li F; Zhai L
    PLoS One; 2022; 17(9):e0274336. PubMed ID: 36137158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China.
    Li J; Zhang X; Wang R; Cao K; Wan L; Ren X; Ding J; Li W
    Front Public Health; 2024; 12():1402581. PubMed ID: 39011324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How mixed ownership affects investment efficiency? evidence from state-owned enterprises in China.
    Huo X; Zhao Y; Dong Z
    PLoS One; 2024; 19(6):e0306190. PubMed ID: 38917198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What shapes the impact of environmental regulation on energy intensity? New evidence from enterprise investment behavior in China.
    Peng W; Lee CC; Xiong K
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53364-53381. PubMed ID: 35288855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green credit guideline and enterprise export green-sophistication.
    Zhou C; Sun Z; Qi S; Li Y; Gao H
    J Environ Manage; 2023 Jun; 336():117648. PubMed ID: 36871455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental regulatory pressures and the short-term debt for long-term investment of heavy-polluting enterprises: quasi-natural experiment from China.
    Liu S; Li D; Chen X
    Environ Sci Pollut Res Int; 2023 May; 30(22):62625-62640. PubMed ID: 36947381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Transformation on Enterprise Green Innovation: Effect and Transmission Mechanism.
    Feng H; Wang F; Song G; Liu L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Financialization of Heavily Polluting Enterprises on Technological Innovation under the Background of Environmental Pollution Control.
    Zhou Y; Du Y; Lei F; Su Z; Feng Y; Li J
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Financial Asset Allocation, Leverage Ratio, and Risk-Taking of Small- and Medium-Sized Enterprises in China: Taking Environment-Related Industries as an Example.
    Chen Q
    J Environ Public Health; 2022; 2022():2431428. PubMed ID: 35733979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitating or inhibiting? The impact of environmental information disclosure on enterprise investment value.
    Feng Y; Guo B; Wang X; Hu F
    Environ Sci Pollut Res Int; 2024 Jan; 31(5):7793-7805. PubMed ID: 38168851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Correlation between Enterprise Internal Control Quality and Research and Development Investment Intensity.
    Hu S; Yang H
    Comput Intell Neurosci; 2022; 2022():1788142. PubMed ID: 35785049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the impact mechanism of heterogeneous environmental regulation on enterprise green technology innovation.
    Wang L; Long Y; Li C
    J Environ Manage; 2022 Nov; 322():116127. PubMed ID: 36067664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green credit policy and the liquidity risks of heavily polluting enterprises.
    Wang T; Liu X; Guo H
    Environ Sci Pollut Res Int; 2023 Mar; 30(13):36928-36937. PubMed ID: 36550254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Regulation, Environmental Decentralization, and Enterprise Environmental Protection Investment: Evidence From China.
    Liu L; Ren G; He B; Zheng M
    Front Public Health; 2022; 10():821488. PubMed ID: 35493359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite Evolutionary Game Analysis of Financial Support for Science-Tech Enterprises' Innovation with Government Participation.
    Liu W; Liu Y; Gu J; Zhao J; Zhang R
    Comput Intell Neurosci; 2022; 2022():5207003. PubMed ID: 35535184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does strategic coupling of TNCs affect their exit from host regions: Empirical analysis of the exit of Taiwanese enterprises from mainland China.
    Chen J; Sun J; Wei S; You X
    PLoS One; 2024; 19(5):e0304254. PubMed ID: 38787816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.